2021 Q1 Form 10-Q Financial Statement

#000143774921011177 Filed on May 06, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $4.814M $2.620M
YoY Change 83.75% -74.95%
Cost Of Revenue $250.8K $109.1K
YoY Change 129.94% -88.08%
Gross Profit $4.563M $2.511M
YoY Change 81.74% -73.69%
Gross Profit Margin 94.79% 95.84%
Selling, General & Admin $4.056M $3.176M
YoY Change 27.71% 0.3%
% of Gross Profit 88.89% 126.5%
Research & Development $2.303M $3.150M
YoY Change -26.9% -21.19%
% of Gross Profit 50.47% 125.47%
Depreciation & Amortization $130.8K $133.2K
YoY Change -1.75% -3.31%
% of Gross Profit 2.87% 5.3%
Operating Expenses $6.359M $6.326M
YoY Change 0.52% -23.48%
Operating Profit -$1.989M -$3.998M
YoY Change -50.24% -282.4%
Interest Expense $0.00 $3.017M
YoY Change -100.0% -23.21%
% of Operating Profit
Other Income/Expense, Net $25.57K $412.4K
YoY Change -93.8% -43.98%
Pretax Income -$1.045M -$11.60M
YoY Change -90.99% -643.09%
Income Tax -$200.0K -$2.700M
% Of Pretax Income
Net Earnings -$812.1K -$8.898M
YoY Change -90.87% -645.94%
Net Earnings / Revenue -16.87% -339.63%
Basic Earnings Per Share -$0.01 -$0.11
Diluted Earnings Per Share -$0.02 -$0.11
COMMON SHARES
Basic Shares Outstanding 76.76M 81.24M
Diluted Shares Outstanding 77.57M 81.24M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $106.5M $77.40M
YoY Change 37.6% -24.19%
Cash & Equivalents $106.5M $77.38M
Short-Term Investments
Other Short-Term Assets $2.000M $2.600M
YoY Change -23.08% -83.12%
Inventory $20.41M $16.34M
Prepaid Expenses
Receivables $4.001M $1.686M
Other Receivables $0.00 $0.00
Total Short-Term Assets $132.9M $98.02M
YoY Change 35.57% -20.65%
LONG-TERM ASSETS
Property, Plant & Equipment $1.987M $2.501M
YoY Change -20.54% -16.29%
Goodwill $898.3K $898.3K
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $419.4K $848.0K
YoY Change -50.54% -14.6%
Total Long-Term Assets $5.877M $20.55M
YoY Change -71.4% -75.21%
TOTAL ASSETS
Total Short-Term Assets $132.9M $98.02M
Total Long-Term Assets $5.877M $20.55M
Total Assets $138.8M $118.6M
YoY Change 17.03% -42.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $446.8K $4.766M
YoY Change -90.63% 121.71%
Accrued Expenses $7.065M $16.66M
YoY Change -57.59% 67.29%
Deferred Revenue $3.574M $13.60M
YoY Change -73.73%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $7.512M $21.42M
YoY Change -64.94% 76.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $8.600M $9.000M
YoY Change -4.44% -22.41%
Total Long-Term Liabilities $8.600M $9.000M
YoY Change -4.44% -89.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.512M $21.42M
Total Long-Term Liabilities $8.600M $9.000M
Total Liabilities $16.08M $30.43M
YoY Change -47.16% -69.68%
SHAREHOLDERS EQUITY
Retained Earnings -$102.5M -$132.9M
YoY Change -22.86% 16.43%
Common Stock $225.2M $221.1M
YoY Change 1.88% 0.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $122.7M $88.14M
YoY Change
Total Liabilities & Shareholders Equity $138.8M $118.6M
YoY Change 17.03% -42.56%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$812.1K -$8.898M
YoY Change -90.87% -645.94%
Depreciation, Depletion And Amortization $130.8K $133.2K
YoY Change -1.75% -3.31%
Cash From Operating Activities -$4.806M $3.322M
YoY Change -244.66% 35324.32%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K -$20.00K
YoY Change -50.0% 100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$13.72K -$15.50K
YoY Change -11.46% 73.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.529M $993.4K
YoY Change 557.29%
Debt Paid & Issued, Net $0.00 $85.91M
YoY Change -100.0%
Cash From Financing Activities -$6.543M -$86.92M
YoY Change -92.47% 153490.0%
NET CHANGE
Cash From Operating Activities -$4.806M $3.322M
Cash From Investing Activities -$13.72K -$15.50K
Cash From Financing Activities -$6.543M -$86.92M
Net Change In Cash -$11.36M -$83.61M
YoY Change -86.41% 148772.25%
FREE CASH FLOW
Cash From Operating Activities -$4.806M $3.322M
Capital Expenditures -$10.00K -$20.00K
Free Cash Flow -$4.796M $3.342M
YoY Change -243.5% 17147.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106527495 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
117890240 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4001259 USD
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
76065078
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76240439
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76240439
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
77195704
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
77195704
CY2020Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2019 siga Lessee Operating Lease First Renewal Term
LesseeOperatingLeaseFirstRenewalTerm
P2Y
CY2019 siga Lessee Operating Lease Second Renewal Term
LesseeOperatingLeaseSecondRenewalTerm
P3Y
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3340263 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
20410371 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
20265519 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1950149 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2112069 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
132889274 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
143608091 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1986888 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2103990 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2572594 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2544053 USD
CY2021Q1 us-gaap Goodwill
Goodwill
898334 USD
CY2020Q4 us-gaap Goodwill
Goodwill
898334 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
419448 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
676923 USD
CY2021Q1 us-gaap Assets
Assets
138766538 USD
CY2020Q4 us-gaap Assets
Assets
149831391 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
446795 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1278217 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7064722 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9205293 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
7511517 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10483510 USD
CY2021Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
5720410 USD
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
6639211 USD
CY2021Q1 us-gaap Other Liabilities
OtherLiabilities
2849744 USD
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
2915401 USD
CY2021Q1 us-gaap Liabilities
Liabilities
16081671 USD
CY2020Q4 us-gaap Liabilities
Liabilities
20038122 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
7625 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
7720 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
225211481 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
224978430 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-102534239 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-95192881 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
122684867 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
129793269 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
138766538 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
149831391 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4813744 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2619765 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
250848 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
109094 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4056184 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3176024 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2302785 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3150105 USD
CY2021Q1 siga Patent Preparation Fees
PatentPreparationFees
193334 USD
CY2020Q1 siga Patent Preparation Fees
PatentPreparationFees
182597 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
6803151 USD
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
6617820 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1989407 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3998055 USD
CY2021Q1 siga Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
-918801 USD
CY2020Q1 siga Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
16065 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4981461 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
-0 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
3016817 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
25568 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
412363 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1045038 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11600035 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-232933 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2702506 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-812105 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-8897529 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76757010
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81240105
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77572587
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81240105
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-812105 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-8897529 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
130826 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
292591 USD
CY2020Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
11303389 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
133163 USD
CY2021Q1 siga Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
-918801 USD
CY2020Q1 siga Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
16065 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
246412 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
259016 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-28541 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2153695 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 USD
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4981461 USD
CY2021Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
0 USD
CY2020Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
887132 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
660996 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2482354 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
144852 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4086487 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-419395 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-22259 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3330241 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1624681 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4806312 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3322447 USD
CY2021Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
13724 USD
CY2020Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
15501 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13724 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15501 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
13361 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9746 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6529348 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
993375 USD
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
-0 USD
CY2020Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
85913459 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6542709 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-86916580 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-11362745 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-83609634 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117890240 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
160986934 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106527495 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77377300 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
73300000 USD
CY2021Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
3400000 USD
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0 USD
CY2021Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2625928 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2628153 USD
CY2021Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
15700529 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
15415425 USD
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2083914 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2221941 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
20410371 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
20265519 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
251824 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
286476 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
486158 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2944932 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2944932 USD
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6216985 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6274944 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4230097 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4170954 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1986888 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2103990 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
130826 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
133163 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3573538 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3280947 USD
CY2021Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
853833 USD
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2933738 USD
CY2021Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
697843 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
919555 USD
CY2021Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
476991 USD
CY2020Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
405176 USD
CY2021Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
336197 USD
CY2021Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
236500 USD
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
150349 USD
CY2021Q1 siga Accrued Research And Development Vendor Costs Current
AccruedResearchAndDevelopmentVendorCostsCurrent
209408 USD
CY2020Q4 siga Accrued Research And Development Vendor Costs Current
AccruedResearchAndDevelopmentVendorCostsCurrent
327606 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7064722 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9205293 USD
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
6639211 USD
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
918801 USD
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
0 USD
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
5720410 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-812105 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-8897529 USD
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
918801 USD
CY2020Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-1730906 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-8897529 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76757010
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81240105
CY2021Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
815577
CY2020Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77572587
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81240105
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2021Q1 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
13200000 USD
CY2021Q1 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
1000000.0 USD
CY2020Q1 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
11600000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2700000 USD
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.223 pure
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.233 pure
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
129793269 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-812105 USD
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
6529348 USD
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y6M29D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0453 pure
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
13361 USD
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
246412 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
122684867 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
97783756 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-8897529 USD
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
993375 USD
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
9746 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
259016 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
88142122 USD
CY2020Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000 USD
CY2021Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1000000
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
6500000 USD
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
100000 USD
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
100000 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
100000 USD
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
100000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
401915 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
368467 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
402078 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
404258 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
406994 USD
CY2021Q1 siga Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
575887 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2559599 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
332140 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2227459 USD

Files In Submission

Name View Source Status
0001437749-21-011177-index-headers.html Edgar Link pending
0001437749-21-011177-index.html Edgar Link pending
0001437749-21-011177.txt Edgar Link pending
0001437749-21-011177-xbrl.zip Edgar Link pending
ex_235585.htm Edgar Link pending
ex_235586.htm Edgar Link pending
ex_235587.htm Edgar Link pending
ex_235588.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
siga-20210331.xsd Edgar Link pending
siga-20210331_cal.xml Edgar Link unprocessable
siga-20210331_def.xml Edgar Link unprocessable
siga-20210331_lab.xml Edgar Link unprocessable
siga-20210331_pre.xml Edgar Link unprocessable
siga20210331_10q.htm Edgar Link pending
siga20210331_10q_htm.xml Edgar Link completed